(Date:7/18/2008)...e-USNewswire/ -- Two consumer,groups today filed a...ent,on human embryonic stem cells held by the Wisc...r Watchdog, formerly The Foundation for Taxpayer a...on appealed to the U.S. Patent,Office,s Board of A...d,WARF,s patent after the two groups requested a r...
(Date:7/18/2008)...ectrum of the animal and human world will be exami...ongress, hosted by the International Society for B...l University in Ithaca., In addition to talks and...y sessions on: , Suzanne Alonzo, assistant prof...rsity, on "When Theory Meets Data: What We Don,t K...
(Date:7/18/2008)...ss campaign to raise awareness, of the importanc...cine compliance rates across the Uni.../ -- The COSHAR Foundation, a,nonprofit organizati...empowerment with a focus on minority and disadvant...areness Day on Saturday, July 19 in conjunction,wi...
(Date:7/18/2008)...dicine for psychiatric patients , , FRID...e found more evidence that a person,s genetic make... to the antidepressant Celexa (citalopram). , S...ound that variations in the serotonin transporter ...his drug, one of the family of medications known a...
Breaking Medicine News(10 mins):Health News:Consumer Groups File Appeal on Challenge of Human Stem Cell Patent Held By WARF 2Health News:The COSHAR Foundation Participates in Annual Women's Health Awareness Day 2Health News:The COSHAR Foundation Participates in Annual Women's Health Awareness Day 3Health News:Gene Variations May Predict Antidepressant Response 2(Date:7/18/2008)... Findings Published in August Issue of Journal of ...king four to five cups of tea a,day may help maint...arch,published in a supplement to the August issue...suggest that four to five cups of tea a day may im...on tea polyphenols, including,research on neurolog...
(Date:7/17/2008)...YORK, July 17 /PRNewswire-USNewswire/ -- The Micha...y announced approximately $2.4,million in total fu...dation,initiative. This annual MJFF program provid...sh potential PD drug targets forward toward clinic...arkinson,s patients,worldwide., "The discovery of...
(Date:7/17/2008)...roval of Second IND Marks Major Corporate Mileston...Program -, ANN ARBOR, Mich., July 17 /PRNewswire/...d the approval of its second investigational new d... clinical trial to study,MPI-676, the Company,s ar...en and progestin for the treatment of endometriosi...
(Date:7/17/2008)... instance where survival increase is observed in a...ving Tavocept in conjunction with standard ...vival increase of 6.5 months seen for patients wit... lung cancer, SAN ANTONIO, July 17 /...today announced that patients with adenocarcinoma ...
Breaking Medicine Technology:New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer 2New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer 3New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer 4New Research Provides Evidence that Tea May Improve Attention and Focus, Keep Brain Cells Healthy, & Influence Genetics in Cancer 5Michael J. Fox Foundation Awards $2.4 Million for Validation of Nine Promising Therapeutic Targets for Parkinson's Disease 2Michael J. Fox Foundation Awards $2.4 Million for Validation of Nine Promising Therapeutic Targets for Parkinson's Disease 3Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis 2Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis 3Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis 4BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial 2BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial 3BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial 4MaxLife Fund Corp purchases a portfolio of Life Settlement Policies with a face value of 244 000 000 695 1Carrington Reports on ISO 9001 3A2000 Inspection at Sabila Industrial in Costa Rica 417 1Carrington Reports on ISO 9001 3A2000 Inspection at Sabila Industrial in Costa Rica 417 2Carrington Reports on ISO 9001 3A2000 Inspection at Sabila Industrial in Costa Rica 417 3Drug could improve pregnancy outcomes in wider range of women with insulin resistance 293 1Drug could improve pregnancy outcomes in wider range of women with insulin resistance 293 2Filtered Cigarettes Blamed for Huge Rise in Type of Lung Cancer 689 1Filtered Cigarettes Blamed for Huge Rise in Type of Lung Cancer 689 2Filtered Cigarettes Blamed for Huge Rise in Type of Lung Cancer 689 3Filtered Cigarettes Blamed for Huge Rise in Type of Lung Cancer 689 4...ENCE, Italy - 8 March 2007 - Cancer drug,developer...unces,positive initial findings from its second, c...cell lung cancer. , This 30-patient trial tested a...rboplatin and paclitaxel chemotherapy.,Investigato...of,patients showed disease stabilisation, while on...
...evelopment program of first-in-class CB1,antagonis...ion and,avoid image as life-style drug , BARCELONA...ce,firm La Merie S.L. reported today that Sanofi-A...ia (rimonabant) has at least,five competitors in c...rlier phases of R&D. While Acomplia received E...
Other Medicine Technology:Antisoma plc (UK) - Second lung cancer trial adds to positive data,on AS1404 2Antisoma plc (UK) - Second lung cancer trial adds to positive data,on AS1404 3Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 2Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 3Take Performance to a Higher Level.
The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC).
FemoStop plus system is a femoral compression system for hemostasis management. It provides a comfortable and efficient "hands off method of compressing the femoral artery and vein after diagnostic
...eal the arterial puncture site. Duett is the only ...e tissue tract with a flowable procoagulant. Usin...ulant - the Duett sealing device is designed to ra...nique in its ability to quickly seal the entire pu...
Medicine Products: